Publication | Closed Access

BCL11B-Mediated Epigenetic Repression Is a Crucial Target for Histone Deacetylase Inhibitors in Cutaneous T-Cell Lymphoma

Hematological MalignancyChromatinCutaneous T-cell LymphomaLymphoid NeoplasiaMalignant Blood DisorderHistone Deacetylase InhibitorsBcl11b-mediated Epigenetic RepressionAdult T-cell Leukemia-lymphomaRadiation OncologyMedicineCell BiologyCancer Research